Syros Pharmaceuticals Inc (Syros Pharmaceuticals Inc (SYRS) has gained Friday morning, with the stock climbing 4.43% in pre-market trading to 6.84.
SYRS's short-term technical score of 15 indicates that the stock has traded less bullishly over the last month than 85% of stocks on the market. In the Biotechnology industry, which ranks 143 out of 146 industries, the stock ranks higher than 40% of stocks.
Syros Pharmaceuticals Inc has risen 2.50% over the past month, closing at $6.04 on April 30. During this period of time, the stock fell as low as $5.01 and as high as $7.03. SYRS has an average analyst recommendation of Strong Buy. The company has an average price target of $16.67.
Syros Pharmaceuticals Inc has a Long-Term Technical rank of 12. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 88% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, SYRS ranks better than 41% of stocks.
Important Dates for Investors in SYRS:
-Syros Pharmaceuticals Inc is set to release earnings on 8/5/2021. During their last earnings release the company posted EPS of $-1.67. -We do not have a set dividend date for Syros Pharmaceuticals Inc at this time. Click Here to get the full Stock Score Report on Syros Pharmaceuticals Inc (SYRS) Stock.